Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Orphan Medical Incorporated

Orphan Medical Incorporated is a development stage company, was formed to acquire, develop and market products of high medical value intended to address inadequately treated or uncommon diseases of well-defined patient populationstreated by health care specialists. A drug has high medical value if it offers a major improvement in the safety or efficacy of patient treatment and has no substantially equivalent substitute.


Contact Details:
13911 Ridgedale Drive, Suite 475
Minnetonka
MN
55305
United States of America
Tel:612 513 6900
Fax:
Email:
WWW:

www.orphan.com/




Loading...

Recent Publications by Orphan Medical Incorporated:

The clinical development of gamma-hydroxybutyrate (GHB).
The discovery of gamma-hydroxybutyrate (GHB) over 40 years ago led to its...
3rd September, 2008
Orphan Medical, Inc., A subsidiary of Jazz Pharmaceuticals, Inc., Palo Curr Drug Saf. 2006 Jan;1(1):99-106.
Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
BACKGROUND AND PURPOSE: To measure the effect of the nocturnal...
8th February, 2006
Orphan Medical, Inc., 13911 Ridgedale Drive Suite 250, Minnetonka, MN Sleep Med. 2005 Sep;6(5):415-21.
DOI Direct Link
Pharmacotherapy for cataplexy.
A variety of medications representing several major drug classes improve...
29th January, 2005
Orphan Medical, Inc., Medical Affairs, 13911 Ridgedale Drive, Suite 250, Sleep Med Rev. 2004 Oct;8(5):355-66.
DOI Direct Link
The Xyrem risk management program.
Sodium oxybate, also known as gamma-hydroxybutyric acid (GHB), was...
13th August, 2004
Orphan Medical Inc., Minnetonka, Minnesota 55305, USA. Drug Saf. 2004;27(5):293-306.
The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients.
This trial was conducted to evaluate the pharmacokinetics and safety of a...
15th June, 2004
Orphan Medical, Inc., 13911 Ridgedale Drive, Suite 250, Minnetonka, MN J Clin Pharmacol. 2004 Mar;44(3):253-7.
DOI Direct Link

View more Orphan Medical Incorporated research publications.

BioNews Results for Orphan Medical Incorporated:

Aastrom to begin second phase-II trial to treat severe chronic heart failure
PharmaBiz:  Nov 12 2009 9:25AM Matching: orphan medical
Aastrom To Initiate Second Phase II Clinical Trial For Treatment of Severe Chronic Heart Failure
Pharmacy Choice:  Nov 12 2009 10:54PM Matching: orphan medical
Medical News: Ikano Therapeutics Receives Orphan Drug Designation For Epilepsy Drug
BioFind:  Nov 11 2009 2:04PM Matching: orphan medical
Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
Therapeutics Daily:  Nov 11 2009 5:47AM Matching: orphan medical
Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
Pharmacy Choice:  Nov 11 2009 4:17AM Matching: orphan medical
Promote your company here: BioNewsCast - Press Release Distribution

View more Orphan Medical Incorporated news.

Orphan Medical Incorporated Clinical Trials:

Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

Orphan Medical Incorporated Patents:

US Patent No.Title
7572605 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
7262219 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
7015200 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
6780889 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
6472431 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

View more Orphan Medical Incorporated patents.

Orphan Medical Incorporated (ORPH) Financial information Links from Barchart

ORPH Quote from from Barchart.com
ORPH Chart from from Barchart.com
ORPH Profile from from Barchart.com
ORPH Opinion from from Barchart.com

View more Orphan Medical Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 423 times since April 2007, the link to the organisation's website has been followed 78 times

Recent Search Terms used to find this page: Orphan Medical | orphan medical | Orphan Med. | orphan medical | orpahn medical orph | .

Search for more companies in Minnetonka

Search for more companies in MN



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Orphan Medical Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.